RxDoctor Payments DataLook up a doctor →

Leigh Ann Pansch, NP

Family · Dayton, OHNPI 1104138601

Payments from drug & device makers

$669,645in general payments, 2019–2025

Across 2,129 payments — averaging $314.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$139K
  • Johnson & Johnson$97K
  • UCB, Inc.$69K
  • Regeneron Healthcare Solutions, Inc.$58K
  • E.r. Squibb & Sons, L.L.C.$44K
  • AbbVie$42K
  • plus $221K from 36 others
$7,066in research payments, 2019–2025

Across 2 payments — averaging $3532.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$7K

What the payments were for

  • Consulting fees$162,34124%
  • Speaking & faculty fees$383,97357%
  • Travel & lodging$76,39011%
  • Food & beverage$46,2577%
  • Education$6850%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$669,645 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$112,984
Medicare patients
592
Services billed
2,409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab11$41,114
Metronidazole85$4,000
Fluorouracil28$2,521
Clobetasol Propionate36$2,436
CiclopiroxCiclopirox Olamine33$1,890
Triamcinolone Acetonide147$1,566
Ketoconazole96$1,227
Doxycycline Hyclate14$293
Hydrocortisone29$279
Mupirocin45$272
Mometasone Furoate16$233
Spironolactone11$123
Minoxidil13$102

Paid to pharmacies, not to this prescriber.

Other family in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →